BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 22502684)

  • 21. Preoperative differential diagnosis of benign and malignant pancreatic lesions--the value of pancreatic secretory trypsin inhibitor, procarboxypeptidase B, CA19-9 and CEA.
    Cerwenka H; Aigner R; Quehenberger F; Werkgartner G; Bacher H; Hauser H; Mischinger HJ
    Hepatogastroenterology; 1997; 44(16):1117-21. PubMed ID: 9261609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum amyloid a as an independent prognostic factor for renal cell carcinoma--a hospital based study from the Western region of Nepal.
    Mittal A; Poudel B; Pandeya DR; Gupta SP; Sathian B; Yadav SK
    Asian Pac J Cancer Prev; 2012; 13(5):2253-5. PubMed ID: 22901203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is tissue polypeptide antigen more accurate than serum CEA for diagnosing pancreatic cancer?
    Panucci A; Fabris C; Del Favero G; Basso D; Di Mario F; Marchioro L; Piccoli A; Lise M; Burlina A; Naccarato R
    J Clin Pathol; 1986 Jan; 39(1):75-7. PubMed ID: 3950034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Role of carcinoembryonic antigen, carbohydrate antigen 19-9 and cytology of bile in diagnosis of biliary and pancreatic cancer].
    Matsuda M; Shimizu Y; Chikamatsu E; Takayanagi K; Ishigure H; Murakami S; Odani K
    Nihon Geka Gakkai Zasshi; 1991 Jun; 92(6):716-21. PubMed ID: 1886576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunological diagnosis of pancreatic cancer by assaying carcinoembryonic antigen (CEA) in pure pancreatic juice.
    Nishida K; Yoshikawa T; Kondo M; Thiele HG
    Hepatogastroenterology; 1980 Dec; 27(6):488-94. PubMed ID: 7203382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative studies of DU-PAN-2, carcinoembryonic antigen, and CA19-9 in the serum and bile of patients with pancreatic and biliary tract diseases: evaluation of the influence of obstructive jaundice.
    Ohshio G; Manabe T; Watanabe Y; Endo K; Kudo H; Suzuki T; Tobe T
    Am J Gastroenterol; 1990 Oct; 85(10):1370-6. PubMed ID: 2220731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic usefulness of plasma carcinoembryonic antigen levels in acute and chronic liver disease.
    Bullen AW; Losowsky MS; Carter S; Patel S; Neville AM
    Gastroenterology; 1977 Oct; 73(4 Pt 1):673-8. PubMed ID: 892370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum and pancreatic juice carcinoembryonic antigen in pancreatic and biliary disease.
    Carr-Locke DL
    Gut; 1980 Aug; 21(8):656-61. PubMed ID: 7429329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of benign and malignant liver disease on the tumour markers CA19-9 and CEA.
    Maestranzi S; Przemioslo R; Mitchell H; Sherwood RA
    Ann Clin Biochem; 1998 Jan; 35 ( Pt 1)():99-103. PubMed ID: 9463746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The value of B7-H4 and carcinoembryonic antigen in diagnosing the benign and malignant pleural effusion].
    Wei F; Wei Y; Li LF; Li GL; Wang GJ
    Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):524-527. PubMed ID: 28728299
    [No Abstract]   [Full Text] [Related]  

  • 31. [Correlation of carcinoembryonic antigen with prognosis of hepatocellular carcinoma after hepatectomy].
    Zhao J; Yan T; Bi X; Zhao H; Huang Z; Zhou J; Li Z; Li C; Cai J
    Zhonghua Zhong Liu Za Zhi; 2014 Jun; 36(6):430-4. PubMed ID: 25241784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EUS and EUS-FNA diagnosis of suspected pancreatic cystic neoplasms: Is the sum of the parts greater than the CEA?
    Oppong KW; Dawwas MF; Charnley RM; Wadehra V; Elamin K; White S; Nayar M
    Pancreatology; 2015; 15(5):531-537. PubMed ID: 26375415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significance of HCG to distinguish parathyroid carcinoma from benign disease and in adding prognostic information: a hospital based study from Nepal.
    Gupta SP; Mittal A; Sathian B
    Asian Pac J Cancer Prev; 2013; 14(1):325-7. PubMed ID: 23534747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suboptimal accuracy of carcinoembryonic antigen in differentiation of mucinous and nonmucinous pancreatic cysts: results of a large multicenter study.
    Gaddam S; Ge PS; Keach JW; Mullady D; Fukami N; Edmundowicz SA; Azar RR; Shah RJ; Murad FM; Kushnir VM; Watson RR; Ghassemi KF; Sedarat A; Komanduri S; Jaiyeola DM; Brauer BC; Yen RD; Amateau SK; Hosford L; Hollander T; Donahue TR; Schulick RD; Edil BH; McCarter M; Gajdos C; Attwell A; Muthusamy VR; Early DS; Wani S
    Gastrointest Endosc; 2015 Dec; 82(6):1060-9. PubMed ID: 26077458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic value of soluble B7-H4 and carcinoembryonic antigen in distinguishing malignant from benign pleural effusion.
    Jing X; Wei F; Li J; Dai L; Wang X; Jia L; Wang H; An L; Yang Y; Zhang G; Cheng Z
    Clin Respir J; 2018 Mar; 12(3):986-990. PubMed ID: 28127951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical value of serum tumour markers CEA, CA 50 and CA 242 in the distinction between malignant versus benign diseases causing jaundice and cholestasis; results from a prospective study.
    Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttilä I; Alhava E
    Anticancer Res; 1992; 12(5):1687-93. PubMed ID: 1332581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are serum and biliary carcinoembryonic antigen and carbohydrate antigen19-9 determinations reliable for differentiation between benign and malignant biliary disease?
    Akdoğan M; Parlak E; Kayhan B; Balk M; Saydam G; Sahin B
    Turk J Gastroenterol; 2003 Sep; 14(3):181-4. PubMed ID: 14655062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Roles of serum and biliary CEA, CA19-9, VEGFR3, and TAC in differentiating between malignant and benign biliary obstructions.
    Ince AT; Yıldız K; Baysal B; Danalıoğlu A; Kocaman O; Tozlu M; Gangarapu V; Sarbay Kemik A; Uysal Ö; Şentürk H
    Turk J Gastroenterol; 2014 Apr; 25(2):162-9. PubMed ID: 25003676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical staining of pancreatic cancer with CA19-9, KM01, unabsorbed CEA, and absorbed CEA. A comparison with normal pancreas and chronic pancreatitis.
    Shimizu M; Saitoh Y; Ohyanagi H; Itoh H
    Arch Pathol Lab Med; 1990 Feb; 114(2):195-200. PubMed ID: 1689141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparative study of the plasma levels of alpha-1 fetoprotein and carcinoembryonic antigen in chronic liver diseases and malignant neoplasias (author's transl)].
    Del Vecchio-Blanco C; Caporaso N; Balzano A; Grande R
    Quad Sclavo Diagn; 1977 Sep; 13(3):288-97. PubMed ID: 77537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.